GLP-1 clinical trials in New York: 30 recruiting now
61 sites in 20 New York cities. Registry checked October 16, 2026.
Screening for a study can take weeks. Two cash programs to check.
No insurance needed.
- SnagRxSponsored$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
- MedviSponsored$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up
Weight-loss studies (10)
Weight-loss study of cagrilintide
Where: Buffalo, Syracuse and The Bronx
What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.
Free to join
Who can join: Children and teens 8 to 18 who are overweight.
Study record on ClinicalTrials.gov
UBMD Physicians Group - Pediatrics - Conventus, Buffalo
SUNY Upstate Medical Univ - Syracuse, Syracuse
Advantage Clinical Trials, The Bronx
Weight-loss study of tirzepatide
Where: Buffalo and Syracuse
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people lose weight.
Free to join
Who can join: Children and teens 12 to 17 with obesity.
Study record on ClinicalTrials.gov
UBMD Pediatrics, Buffalo
SUNY Upstate Medical University, Syracuse
Weight-loss study of maridebart cafraglutide
Where: New York and Rochester
What: Tests whether a study medicine from Amgen, Maridebart Cafraglutide, can help people lose weight.
Free to join
Who can join: Adults 18+ with obesity or overweight, BMI 25+.
Study record on ClinicalTrials.gov
Icahn School of Medicine at Mount Sinai, New York
Rochester Clinical Research, Rochester
Show 7 more studies
Weight-loss study of semaglutide
Where: Syracuse and West Seneca
What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.
Free to join
Who can join: Adults 18+ who are overweight.
Study record on ClinicalTrials.gov
Ichor Research, Syracuse
Southgate Medical Group, LLP, West Seneca
Weight-loss study of orforglipron
Where: Buffalo
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 17 with obesity.
Study record on ClinicalTrials.gov
UBMD Pediatrics, Buffalo
Weight-loss study of cagrisema
Where: West Seneca
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.
Free to join
Who can join: Adults 18+ with obesity, BMI 35+.
Study record on ClinicalTrials.gov
Southgate Medical Group, LLP, West Seneca
Weight-loss study of tirzepatide
Where: Buffalo
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 11 with obesity.
Study record on ClinicalTrials.gov
UBMD Pediatrics, Buffalo
Weight-loss study of LY3305677
Where: Amherst, East Syracuse, Port Jefferson Station and 1 more city
What: Tests whether an investigational medicine from Lilly, LY3305677, can help people lose weight.
Free to join
Who can join: Adults 18 to 75 with obesity, BMI 27+.
Call the site: 585-288-0890Study record on ClinicalTrials.gov
Dent Neurologic Institute, Amherst
Velocity Clinical Research, Syracuse, East Syracuse
North Suffolk Neurology, Port Jefferson Station
Rochester Clinical Research, LLC, Rochester. 585-288-0890
Weight-loss study of olatorepatide
Where: New York and Rochester
What: Tests whether a GLP-1 and GIP medicine from Regeneron Pharmaceuticals, olatorepatide, can help people lose weight.
Free to join
Who can join: Adults 18+ with obesity or overweight, BMI 27+.
Study record on ClinicalTrials.gov
NYC Research Inc, New York
Rochester Clinical Research, Rochester
Weight-loss study
Where: Buffalo
What: A study in people with type 2 diabetes.
Free to join
Who can join: Adults 18 to 60 with obesity or overweight.
Call the site: (716) 829 - 5820Study record on ClinicalTrials.gov
State University of New York at Buffalo, South Campus, Buffalo. (716) 829 - 5820
Type 2 diabetes studies (3)
Type 2 diabetes study of cagrisema
Where: Buffalo and New York
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Children and teens 10 to 18 with type 2 diabetes.
Study record on ClinicalTrials.gov
UBMD Pediatrics, Buffalo
NYU Langone Orthopedic Center, New York
Type 2 diabetes study of survodutide
Where: Brooklyn
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
Ellipsis Research Group - Brooklyn, Brooklyn. 833-602-2368
Type 2 diabetes study of LY3457263
Where: Long Island City, Staten Island and West Seneca
What: Tests whether an investigational medicine from Lilly, LY3457263, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes, BMI 27+.
Call the site: 516-574-9232Study record on ClinicalTrials.gov
NYC Research INC, Long Island City. 516-574-9232
Richmond University Medical Center, Staten Island
Southgate Medical Group, West Seneca. 716-712-1004
Other GLP-1 studies in New York (17)
Fatty liver disease (MASLD) study of retatrutide
Where: Buffalo, New York and Yonkers
What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.
Call the site: 716-535-1850Study record on ClinicalTrials.gov
Research Foundation of SUNY - University of Buffalo, Buffalo. 716-535-1850
IMA Clinical Research Manhattan, New York
New York Gastroenterology Associates, New York
NYU Langone Health, New York. 646-501-2948
Care Access - Yonkers, Yonkers
Fatty liver disease with liver scarring study of survodutide
Where: Brooklyn, Laurelton, New York and 1 more city
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
Call the site: 833-602-2368Study record on ClinicalTrials.gov
NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn. 833-602-2368
Basil Clinical, Laurelton. 833-602-2368
Icahn School of Medicine at Mount Sinai, New York. 833-602-2368
University of Rochester Medical Center, Rochester. 833-602-2368
Fatty liver disease (also called MASH or NASH) study of survodutide
Where: Brooklyn, Laurelton, New York and 1 more city
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn. 833-602-2368
Basil Clinical, Laurelton. 833-602-2368
Icahn School of Medicine at Mount Sinai, New York. 833-602-2368
University of Rochester Medical Center, Rochester. 833-602-2368
Show 14 more studies
Ulcerative colitis study of tirzepatide
Where: New York and Yonkers
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.
Call the site: 212-369-2490Study record on ClinicalTrials.gov
Icahn School of Medicine at Mount Sinai, New York
New York Gastroenterology Associates, New York. 212-369-2490
Care Access - Yonkers, Yonkers
Prehypertension study of orforglipron
Where: Hartsdale, Long Island City and Rochester
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.
Free to join
Who can join: Adults 18+ who are overweight, BMI 25+.
Call the site: 914-341-2346Study record on ClinicalTrials.gov
Drug Trials America, Hartsdale. 914-341-2346
NYC Research INC, Long Island City. 516-574-9232
Rochester Clinical Research, LLC, Rochester. 585-288-0890
Crohn's disease study of tirzepatide
Where: New York and Yonkers
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.
Call the site: 212-369-2490Study record on ClinicalTrials.gov
New York Gastroenterology Associates, New York. 212-369-2490
Care Access - Yonkers, Yonkers
Nausea and vomiting study of tradipitant
Where: New York and Syosset
What: Tests whether an investigational medicine from Vanda Pharmaceuticals, tradipitant, can help people reduce nausea and vomiting.
Free to join
Who can join: Adults 18 to 65 with nausea and vomiting, BMI 25+.
Call the site: 202-734-3400Study record on ClinicalTrials.gov
Vanda Investigational Site, New York. 202-734-3400
Vanda Investigational Site, Syosset. (202) 734-3400
ASCVD study of semaglutide
Where: New York
What: Tests whether a GLP-1 medicine, semaglutide, can help people lower blood sugar.
Free to join
Who can join: Adults 40 to 80 with type 2 diabetes.
Call the site: 212-851-5492Study record on ClinicalTrials.gov
Naomi Berrie Diabetes Center at New York Presbyterian-Columbia University, New York. 212-851-5492
Growth hormone deficiency study of liraglutide
Where: New York
What: Tests a GLP-1 medicine, liraglutide, in people with growth hormone deficiency.
Free to join
Who can join: Adults 18 to 45 with growth hormone deficiency, BMI 19+.
Call the site: 212-305-2254Study record on ClinicalTrials.gov
Neuroendocrine Unit and Pituitary Center, Columbia University Irving Medical Center, New York. 212-305-2254
Psoriasis study of tirzepatide
Where: New York
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people calm psoriasis.
Free to join
Who can join: Adults 18+ with psoriasis, BMI 27+.
Call the site: 212-466-6550Study record on ClinicalTrials.gov
Equity Medical, New York. 212-466-6550
Breast cancer study of tirzepatide
Where: New York
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with breast cancer lose weight.
Free to join
Who can join: Adults 18+, women only with obesity, BMI 27.5+.
Call the site: 646-962-2111Study record on ClinicalTrials.gov
Weill Cornell Medicine, New York. 646-962-2111
Diastolic heart failure study of tirzepatide
Where: New York
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with diastolic heart failure lose weight.
Free to join
Who can join: Adults 40+ with diastolic heart failure, BMI 30+.
Study record on ClinicalTrials.gov
Columbia University Irving Medical Center (CUIMC) / NewYork Presbyterian Hospital (NYP), New York
Opioid use disorder study of semaglutide
Where: New York
What: Tests whether a GLP-1 medicine, semaglutide, can help people with opioid use disorder cut down on opioids.
Free to join
Who can join: Adults 18 to 75 with opioid use disorder, BMI 18+.
Call the site: 929 573 0673Study record on ClinicalTrials.gov
NYU Langone Health, New York. 929 573 0673
Chronic kidney disease study of NNC0519-0130
Where: Albany
What: Tests whether an investigational medicine from Novo Nordisk, NNC0519-0130, can help people with chronic kidney disease protect their kidneys.
Free to join
Who can join: Adults 18+ with chronic kidney disease, BMI 27+.
Study record on ClinicalTrials.gov
Albany Medical College, Albany
Crohn's disease study of tirzepatide
Where: New York
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with Crohn's disease calm gut inflammation.
Free to join
Who can join: Adults 18 to 80 with Crohn's disease, BMI 25+.
Call the site: 212-327-8270Study record on ClinicalTrials.gov
Icahn School of Medicine at Mount Sinai, New York. 212-327-8270
Multiple sclerosis study of NLY01
Where: New York
What: Tests an investigational medicine, NLY01, in people with multiple sclerosis.
Free to join
Who can join: Adults 18 to 60 with multiple sclerosis, BMI 27+.
Call the site: 212-241-4364Study record on ClinicalTrials.gov
Mount Sinai School of Medicine, New York. 212-241-4364
Endometrial cancer study of tirzepatide
Where: Commack, Harrison, New York and 1 more city
What: Tests a GLP-1 and GIP medicine, tirzepatide, in people with endometrial cancer.
Free to join
Who can join: Adults 18+, women only with endometrial cancer, BMI 25+.
Call the site: 646-888-5427Study record on ClinicalTrials.gov
Memorial Sloan Kettering Commack, Commack. 646-888-5427
Memorial Sloan Kettering Westchester, Harrison. 646-888-5427
Memorial Sloan Kettering Cancer Center, New York. 646-888-5427
Memorial Sloan Kettering Nassau, Uniondale. 646-888-5427
Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.
Clinical trials by state
Every state with a GLP-1 study recruiting today. 48 of them.
- Alabama (18)
- Arizona (22)
- Arkansas (5)
- California (53)
- Colorado (18)
- Connecticut (14)
- Delaware (1)
- District of Columbia (1)
- Florida (43)
- Georgia (23)
- Hawaii (6)
- Idaho (12)
- Illinois (30)
- Indiana (20)
- Iowa (10)
- Kansas (14)
- Kentucky (18)
- Louisiana (14)
- Maine (1)
- Maryland (25)
- Massachusetts (20)
- Michigan (21)
- Minnesota (19)
- Mississippi (7)
- Missouri (22)
- Montana (3)
- Nebraska (7)
- Nevada (11)
- New Hampshire (3)
- New Jersey (11)
- New Mexico (5)
- New York (30)
- North Carolina (31)
- North Dakota (5)
- Ohio (31)
- Oklahoma (12)
- Oregon (5)
- Pennsylvania (33)
- Rhode Island (5)
- South Carolina (25)
- South Dakota (2)
- Tennessee (27)
- Texas (56)
- Utah (14)
- Virginia (28)
- Washington (24)
- West Virginia (5)
- Wisconsin (7)